Bvf Inc Inventiva S.A. Put Options Transaction History
Bvf Inc
- $2.54 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IVA
# of Institutions
12Shares Held
4.93MCall Options Held
0Put Options Held
0-
Yiheng Capital Management, L.P. San Francisco, CA2.64MShares$9.71 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD1.46MShares$5.37 Million0.39% of portfolio
-
Commonwealth Equity Services, LLC54.3KShares$199,3430.0% of portfolio
-
Ubs Group Ag27.4KShares$100,7340.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il23.4KShares$85,8190.0% of portfolio
About Inventiva S.A.
- Ticker IVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,134,200
- Market Cap $155M
- Description
- Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...